Clinical Trial Update: Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)

View source ↗

Summary

A chart review study evaluating real-world use of Ozurdex (dexamethasone intravitreal implant) 0.7 mg in participants with diabetic macular edema; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Diabetic Macular Edema | Status: COMPLETED | Results posted: 2020-06-22